Increased frequency of late-senescent T cells lacking CD127 in chronic hepatitis C disease

Eur J Clin Invest. 2015 May;45(5):466-74. doi: 10.1111/eci.12429. Epub 2015 Mar 16.

Abstract

Background: Hepatitis C virus (HCV) causes persistent disease in ~85% of infected individuals, where the viral replication appears to be tightly controlled by HCV-specific CD8+ T cells. Accumulation of senescent T cells during infection results in considerable loss of functional HCV-specific immune responses.

Materials and methods: We characterized the distinct T-cell phenotypes based on the expression of costimulatory molecules CD28 and CD27, senescence markers PD-1 and CD57, chronic immune activation markers CD38 and HLA-DR, and survival marker CD127 (IL-7R) by flow cytometry following activation of T cells using HCV peptides and phytohemagglutinin.

Results: HCV-specific CD4+ and CD8+ T cells from chronic HCV (CHC) patients showed increased expression of PD-1. Furthermore, virus-specific CD4+ T cells of CHC-infected subjects displayed relatively increased expression of HLA-DR and CD38 relative to HCV-specific CD8+ T cells. The CD4+ and CD8+ T cells from HCV-infected individuals showed significant increase of late-differentiated T cells suggestive of immunosenescence. In addition, we found that the plasma viral loads positively correlated with the levels of CD57 and PD-1 expressed on T cells.

Conclusions: Chronic HCV infection results in increased turnover of late-senescent T cells that lack survival potentials, possibly contributing to viral persistence. Our findings challenge the prominence of senescent T-cell phenotypes in clinical hepatitis C infection.

Keywords: CD38; CD57; HCV infection; IL-7R; PD-1; immunosenescence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADP-ribosyl Cyclase 1 / immunology
  • Adult
  • CD28 Antigens / immunology
  • CD4-Positive T-Lymphocytes / immunology*
  • CD57 Antigens / immunology
  • CD8-Positive T-Lymphocytes / immunology*
  • Case-Control Studies
  • Cellular Senescence / immunology*
  • Female
  • Flow Cytometry
  • HLA-DR Antigens / immunology
  • Hepatitis C, Chronic / immunology*
  • Humans
  • Interleukin-7 Receptor alpha Subunit / immunology*
  • Lymphocyte Activation / immunology
  • Male
  • Middle Aged
  • Programmed Cell Death 1 Receptor / immunology
  • T-Lymphocytes / immunology
  • Tumor Necrosis Factor Receptor Superfamily, Member 7 / immunology
  • Young Adult

Substances

  • CD28 Antigens
  • CD57 Antigens
  • HLA-DR Antigens
  • Interleukin-7 Receptor alpha Subunit
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • Tumor Necrosis Factor Receptor Superfamily, Member 7
  • ADP-ribosyl Cyclase 1